|
TNRC6B expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 8.103600E-01 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
7.470600E-01 |
| Normal-vs-Stage2 |
8.984400E-01 |
| Normal-vs-Stage3 |
1.083980E-01 |
| Normal-vs-Stage4 |
6.27079999999669E-05 |
| Stage1-vs-Stage2 |
7.634000E-01 |
| Stage1-vs-Stage3 |
1.998160E-01 |
| Stage1-vs-Stage4 |
1.137970E-03 |
| Stage2-vs-Stage3 |
2.681200E-01 |
| Stage2-vs-Stage4 |
2.244400E-02 |
| Stage3-vs-Stage4 |
1.592040E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
6.158400E-01 |
| Normal-vs-AfricanAmerican |
6.484000E-01 |
| Normal-vs-Asian |
3.900900E-03 |
| Caucasian-vs-AfricanAmerican |
9.165400E-01 |
| Caucasian-vs-Asian |
1.655790E-01 |
| AfricanAmerican-vs-Asian |
1.797630E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
5.904800E-01 |
| Normal-vs-Female |
6.506200E-01 |
| Male-vs-Female |
3.665000E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
4.698500E-02 |
| Normal-vs-Extreme_Weight |
1.523240E-01 |
| Normal-vs-Obese |
2.868000E-01 |
| Normal-vs-Extreme_Obese |
8.110200E-01 |
| Normal_Weight-vs-Extreme_Weight |
5.439400E-01 |
| Normal_Weight-vs-Obese |
1.654350E-02 |
| Normal_Weight-vs-Extreme_Obese |
4.111800E-01 |
| Extreme_Weight-vs-Obese |
3.701700E-02 |
| Extreme_Weight-vs-Extreme_Obese |
6.844600E-01 |
| Obese-vs-Extreme_Obese |
5.033600E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
7.258800E-01 |
| Normal-vs-Age(41-60Yrs) |
2.348600E-01 |
| Normal-vs-Age(61-80Yrs) |
2.168200E-01 |
| Normal-vs-Age(81-100Yrs) |
1.677310E-03 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
4.112400E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
7.856000E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
7.952000E-02 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
2.368000E-02 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
1.755680E-02 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
1.612420E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
7.788100E-02 |
| Normal-VS-Type2 PRCC |
7.96220000000014E-05 |
| Normal-VS-KIRP CIMP |
2.643700E-02 |
| Normal-VS-Unclassified PRCC |
8.860000E-01 |
| Type1 PRCC-VS-Type2 PRCC |
3.46909999615619E-08 |
| Type1 PRCC-VS-KIRP CIMP |
7.704200E-02 |
| Type1 PRCC-VS-Unclassified PRCC |
3.821600E-01 |
| Type2 PRCC-VS-KIRP CIMP |
6.861800E-01 |
| Type2 PRCC-VS-Unclassified PRCC |
1.237530E-02 |
| KIRP CIMP-VS-Unclassified PRCC |
2.322200E-01 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
1.433880E-02 |
| Normal-vs-N1 |
5.935600E-02 |
| Normal-vs-N2 |
4.687600E-02 |
| N0-vs-N1 |
8.859200E-01 |
| N0-vs-N2 |
3.161800E-01 |
| N1-vs-N2 |
5.856400E-01 |
|
|
